Levomefolic acid Withdrawn Phase 4 Trials for Menstrual Related Mood Disorder / Premenstrual Dysphoric Disorder (PMDD) / Premenstrual Syndrome (PMS) / Premenstrual tension with edema Treatment

Indications	Status	Purpose	Phase
DBCOND0123277 (Menstrual Related Mood Disorder) DBCOND0065799 (Premenstrual Dysphoric Disorder (PMDD)) DBCOND0066800 (Premenstrual Syndrome (PMS)) DBCOND0022593 (Premenstrual tension with edema)	Withdrawn	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04123483	EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders	1,2-Docosahexanoyl-sn-glycero-3-phosphoserine (DB11318) 1,2-icosapentoyl-sn-glycero-3-phosphoserine (DB14096) Betaine (DB06756) Cobamamide (DB11191) Cocarboxylase (DB01987) Ferrous cysteine glycinate (DB11197) Flavin adenine dinucleotide (DB03147) Folic acid (DB00158) L-threonic acid (DB11192) Leucovorin (DB00650) Levomefolic acid (DB11256) Magnesium ascorbate (DB14484) NADH (DB00157) Phosphatidyl serine (DB00144) Pyridoxal phosphate (DB00114) Zinc ascorbate (DB14485)